A 0 1 0 1 O
history 2 9 2 9 O
at 10 12 10 12 O
least 13 18 13 18 O
one 19 22 19 22 B-lower_bound
infection 23 32 23 32 B-chronic_disease
due 33 36 33 36 O
to 37 39 37 39 O
ESC 40 43 40 43 O
- 43 44 43 44 O
R 44 45 44 45 O
Enterobacteriaceae 46 64 46 64 O

Active 0 6 65 71 O
inflammatory 7 19 72 84 B-chronic_disease
gastrointestinal 20 36 85 101 I-chronic_disease
disease 37 44 102 109 I-chronic_disease
, 44 45 109 110 O
such 46 50 111 115 O
as 51 53 116 118 O
inflammatory 54 66 119 131 B-chronic_disease
bowel 67 72 132 137 I-chronic_disease
disease 73 80 138 145 I-chronic_disease

Active 0 6 146 152 B-chronic_disease
mucositis 7 16 153 162 I-chronic_disease
or 17 19 163 165 O
acute 20 25 166 171 B-chronic_disease
graft 26 31 172 177 I-chronic_disease
versus 32 38 178 184 I-chronic_disease
host 39 43 185 189 I-chronic_disease
disease 44 51 190 197 I-chronic_disease
of 52 54 198 200 O
the 55 58 201 204 O
gastrointestinal 59 75 205 221 O
tract 76 81 222 227 O

Allergy 0 7 228 235 O
or 8 10 236 238 O
hypersensitivity 11 27 239 255 O
to 28 30 256 258 O
omeprazole 31 41 259 269 B-allergy_name
and 42 45 270 273 O
polyethylene 46 58 274 286 B-allergy_name
glycol 59 65 287 293 I-allergy_name

Bleeding 0 8 294 302 B-chronic_disease
diatheses 9 18 303 312 I-chronic_disease

Concurrent 0 10 313 323 B-treatment
abdominal 11 20 324 333 I-treatment
radiation 21 30 334 343 I-treatment
therapy 31 38 344 351 I-treatment

Current 0 7 352 359 O
history 8 15 360 367 O
of 16 18 368 370 O
frequent 19 27 371 379 O
( 28 29 380 381 O
> 29 30 381 382 O
1 30 31 382 383 B-lower_bound
per 32 35 384 387 O
week 36 40 388 392 O
) 40 41 392 393 O
vomiting 42 50 394 402 O

ESC 0 3 403 406 B-treatment
- 3 4 406 407 I-treatment
R 4 5 407 408 I-treatment
isolates 6 14 409 417 O
will 15 19 418 422 O
be 20 22 423 425 O
defined 23 30 426 433 O
as 31 33 434 436 O
those 34 39 437 442 O
non 40 43 443 446 O
- 43 44 446 447 O
susceptible 44 55 447 458 O
to 56 58 459 461 O
ceftriaxone 59 70 462 473 B-treatment
, 70 71 473 474 O
cefotaxime 72 82 475 485 B-treatment
, 82 83 485 486 O
or 84 86 487 489 O
ceftazidime 87 98 490 501 B-treatment

Lack 0 4 502 506 O
of 5 7 507 509 O
intestinal 8 18 510 520 O
carriage 19 27 521 529 O
of 28 30 530 532 O
ESC 31 34 533 536 B-chronic_disease
- 34 35 536 537 I-chronic_disease
R 35 36 537 538 I-chronic_disease
Enterobacteriaceae 37 55 539 557 I-chronic_disease
( 56 57 558 559 O
negative 57 65 559 567 O
selective 66 75 568 577 O
stool 76 81 578 583 O
culture 82 89 584 591 O
for 90 93 592 595 O
ESC 94 97 596 599 O
- 97 98 599 600 O
R 98 99 600 601 O
Enterobacteriaceae 100 118 602 620 O
) 118 119 620 621 O

Patients 0 8 622 630 O
with 9 13 631 635 O
any 14 17 636 639 O
history 18 25 640 647 O
of 26 28 648 650 O
malignancy 29 39 651 661 B-cancer
or 40 42 662 664 O
any 43 46 665 668 O
immunocompromised 47 64 669 686 O
state 65 70 687 692 O
( 71 72 693 694 O
e.g. 72 76 694 698 O
absolute 77 85 699 707 B-clinical_variable
neutrophil 86 96 708 718 I-clinical_variable
count 97 102 719 724 I-clinical_variable
outside 103 110 725 732 O
the 111 114 733 736 O
normal 115 121 737 743 O
range 122 127 744 749 O
) 127 128 749 750 O
induced 129 136 751 758 O
by 137 139 759 761 O
disease 140 147 762 769 O
or 148 150 770 772 O
therapy 151 158 773 780 B-treatment

Patients 0 8 781 789 O
with 9 13 790 794 O
current 14 21 795 802 O
active 22 28 803 809 O
ESC 29 32 810 813 B-chronic_disease
- 32 33 813 814 I-chronic_disease
R 33 34 814 815 I-chronic_disease
Enterobacteriaceae 35 53 816 834 I-chronic_disease
infection 54 63 835 844 I-chronic_disease
who 64 67 845 848 O
have 68 72 849 853 O
not 73 76 854 857 O
yet 77 80 858 861 O
completed 81 90 862 871 O
antibiotic 91 101 872 882 B-treatment
treatment 102 111 883 892 I-treatment
will 112 116 893 897 O
be 117 119 898 900 O
excluded 120 128 901 909 O
until 129 134 910 915 O
their 135 140 916 921 O
treatment 141 150 922 931 O
is 151 153 932 934 O
completed 154 163 935 944 O

Patients 0 8 945 953 O
with 9 13 954 958 O
past 14 18 959 963 O
or 19 21 964 966 O
current 22 29 967 974 O
use 30 33 975 978 O
of 34 36 979 981 O
systemic 37 45 982 990 B-treatment
immunosuppressive 46 63 991 1008 I-treatment
agents 64 70 1009 1015 I-treatment
will 71 75 1016 1020 O
be 76 78 1021 1023 O
excluded 79 87 1024 1032 O
. 87 88 1032 1033 O
Receipt 89 96 1034 1041 O
of 97 99 1042 1044 O
non 100 103 1045 1048 B-treatment
- 103 104 1048 1049 I-treatment
systemic 104 112 1049 1057 I-treatment
agents 113 119 1058 1064 I-treatment
such 120 124 1065 1069 O
as 125 127 1070 1072 O
inhaled 128 135 1073 1080 B-treatment
, 135 136 1080 1081 O
nasal 137 142 1082 1087 B-treatment
, 142 143 1087 1088 O
or 144 146 1089 1091 O
topical 147 154 1092 1099 B-treatment
steroids 155 163 1100 1108 I-treatment
or 164 166 1109 1111 O
immune 167 173 1112 1118 B-treatment
- 173 174 1118 1119 I-treatment
modulating 174 184 1119 1129 I-treatment
agents 185 191 1130 1136 I-treatment

Pregnancy 0 9 1137 1146 B-pregnancy

Presence 0 8 1147 1155 O
of 9 11 1156 1158 O
a 12 13 1159 1160 O
ventriculoperitoneal 14 34 1161 1181 B-treatment
shunt 35 40 1182 1187 I-treatment
or 41 43 1188 1190 O
other 44 49 1191 1196 O
intrabdominal 50 63 1197 1210 O
device 64 70 1211 1217 O
, 70 71 1217 1218 O
receipt 72 79 1219 1226 O
of 80 82 1227 1229 O
renal 83 88 1230 1235 B-treatment
dialysis 89 97 1236 1244 I-treatment
, 97 98 1244 1245 O
presence 99 107 1246 1254 O
of 108 110 1255 1257 O
ascites 111 118 1258 1265 B-chronic_disease
, 118 119 1265 1266 O
or 120 122 1267 1269 O
other 123 128 1270 1275 O
conditions 129 139 1276 1286 O
/ 139 140 1286 1287 O
devices 140 147 1287 1294 O
that 148 152 1295 1299 O
would 153 158 1300 1305 O
increase 159 167 1306 1314 O
the 168 171 1315 1318 O
risk 172 176 1319 1323 O
of 177 179 1324 1326 O
peritonitis 180 191 1327 1338 B-chronic_disease

Subject 0 7 1339 1346 O
must 8 12 1347 1351 O
be 13 15 1352 1354 O
willing 16 23 1355 1362 O
and 24 27 1363 1366 O
able 28 32 1367 1371 O
to 33 35 1372 1374 O
provide 36 43 1375 1382 O
written 44 51 1383 1390 O
informed 52 60 1391 1399 O
consent 61 68 1400 1407 O
or 69 71 1408 1410 O
assent 72 78 1411 1417 O
( 79 80 1418 1419 O
as 80 82 1419 1421 O
appropriate 83 94 1422 1433 O
by 95 97 1434 1436 O
age 98 101 1437 1440 B-age
) 101 102 1440 1441 O

between 0 7 1442 1449 O
7 8 9 1450 1451 B-lower_bound
and 10 13 1452 1455 O
21 14 16 1456 1458 B-upper_bound
years 17 22 1459 1464 I-upper_bound
of 23 25 1465 1467 O
age 26 29 1468 1471 B-age

